Crossref
Hepatitis C Virus Direct Acting Antivirals and Disruptive Innovation
Journal of Strategic Innovation and Sustainability · 2017
DOI: 10.33423/jsis.v12i2.802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Strategic Innovation and Sustainability, 2017.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2017). Hepatitis C Virus Direct Acting Antivirals and Disruptive Innovation. Journal of Strategic Innovation and Sustainability. https://doi.org/10.33423/jsis.v12i2.802
Vancouver
Hepatitis C Virus Direct Acting Antivirals and Disruptive Innovation. Journal of Strategic Innovation and Sustainability. 2017. doi:10.33423/jsis.v12i2.802
BibTeX
@article{euvimed2017,
title = {Hepatitis C Virus Direct Acting Antivirals and Disruptive Innovation},
journal = {Journal of Strategic Innovation and Sustainability},
year = {2017},
doi = {10.33423/jsis.v12i2.802}
}
EUVIMED